tiprankstipranks
Trending News
More News >
American Healthcare REIT, Inc. (AHR)
NYSE:AHR
US Market
Advertisement

American Healthcare REIT, Inc. (AHR) AI Stock Analysis

Compare
182 Followers

Top Page

AHR

American Healthcare REIT, Inc.

(NYSE:AHR)

Rating:72Outperform
Price Target:
$45.00
▲(11.25% Upside)
The overall stock score of 71.5 reflects strong earnings call performance and technical momentum, offset by concerns over profitability and valuation. The company's strategic growth initiatives and improved leverage metrics are positive, but the negative P/E ratio and overbought technical indicators warrant caution.
Positive Factors
Acquisition Strategy
The $300 million acquisition pipeline of deals already awarded to AHR could drive additional growth.
Earnings Growth
The stock price is expected to react positively due to a solid earnings beat and one of the biggest guidance raises this quarter.
Financial Performance
AHR has among the strongest balance sheets and highest earnings growth profiles in our coverage universe.
Negative Factors
Missing Financial Data
The income statement published in the earnings press release is missing values for Loss from unconsolidated entities.
NOI Comparison
1Q total portfolio Same-Store NOI was 15.1% compared to 21.6% in the prior quarter.

American Healthcare REIT, Inc. (AHR) vs. SPDR S&P 500 ETF (SPY)

American Healthcare REIT, Inc. Business Overview & Revenue Model

Company DescriptionAmerican Healthcare REIT, Inc. (AHR) is a real estate investment trust (REIT) focused on owning and managing a diverse portfolio of healthcare-related properties across the United States. The company primarily invests in medical office buildings, senior housing, skilled nursing facilities, hospitals, and other healthcare facilities. AHR aims to provide stable and growing income to its investors through strategic acquisitions and effective property management in the healthcare sector.
How the Company Makes MoneyAmerican Healthcare REIT, Inc. generates revenue primarily through leasing its healthcare properties to healthcare providers and operators. The company earns rental income from long-term leases, which are often structured with inflation escalators or rent increases over time. AHR also benefits from property appreciation and capital gains by strategically acquiring and disposing of assets within its portfolio. Additionally, the company may form joint ventures or partnerships with healthcare operators to enhance property management and operational efficiency, further contributing to its earnings.

American Healthcare REIT, Inc. Earnings Call Summary

Earnings Call Date:Aug 07, 2025
(Q2-2025)
|
% Change Since: 1.48%|
Next Earnings Date:Nov 18, 2025
Earnings Call Sentiment Positive
The earnings call highlighted strong financial performance with significant same-store NOI growth, successful acquisitions, and improved leverage metrics. Key achievements include the Great Place to Work Certification and increased Medicare Advantage concentration. However, challenges persist in the outpatient medical segment and navigating fragmented Medicare Advantage contracts. Overall, the positive aspects significantly outweigh the lowlights.
Q2-2025 Updates
Positive Updates
Strong Same-Store NOI Growth
Total portfolio same-store NOI growth of 13.9% in Q2 2025 compared to Q2 2024, with expectations for double-digit growth for the remainder of the year.
Successful Acquisitions and Pipeline Growth
Approximately $255 million in acquisitions closed year-to-date, with over $300 million in the pipeline, indicating a strong future growth potential.
Improvement in Leverage Metrics
Net debt to EBITDA reduced to 3.7x at the end of Q2 2025, down from 4.5x on March 31, 2025.
Great Place to Work Certification
American Healthcare REIT was awarded the Great Place to Work Certification, highlighting employee satisfaction and workplace culture.
Medicare Advantage Growth
Trilogy's concentration with Medicare Advantage increased to 7.2% of resident days in Q2 2025, up from 5.8% a year ago, contributing to revenue growth.
Increased 2025 Guidance
Full-year 2025 NFFO per share guidance raised to $1.64 to $1.68, up from the previous range of $1.58 to $1.64.
Negative Updates
Outpatient Medical Segment Challenges
Outpatient medical segment showed low growth with guidance ranging from 1% to 1.5% in same-store NOI growth, indicating sluggish performance.
Potential Challenges in Medicare Contracts
Fragmented nature of Medicare Advantage contracts may pose challenges in negotiating higher rates and managing quality mix.
Company Guidance
During the American Healthcare REIT Second Quarter 2025 Earnings Conference Call, the company reported a robust performance with several key metrics reflecting their growth trajectory. The total portfolio same-store NOI growth for Q2 2025 was reported at 13.9% compared to the same period in 2024, with the Trilogy segment achieving an impressive 18.3% growth in same-store NOI year-over-year. The SHOP segment demonstrated even stronger performance with a same-store NOI growth of 23% year-over-year. The company has also raised its full year 2025 normalized funds from operations (NFFO) per share guidance to a range of $1.64 to $1.68, reflecting increased confidence in their financial outlook. On the acquisitions front, American Healthcare REIT has closed approximately $255 million in acquisitions so far in 2025, with over $300 million of deals still in the pipeline. They also reported a significant improvement in their leverage metrics, with net debt to EBITDA reduced to 3.7x at the end of Q2, down from 4.5x at the end of Q1 2025. The company is focusing on high-quality long-term care assets, particularly within the RIDEA structure, and continues to explore further external growth opportunities.

American Healthcare REIT, Inc. Financial Statement Overview

Summary
American Healthcare REIT, Inc. demonstrates robust revenue growth and improved operational efficiency. Despite improvements in cash flow and debt reduction, the company struggles with maintaining profitability, as evidenced by recurring net losses. The balance sheet shows a strong equity position but indicates potential risks associated with asset leverage.
Income Statement
65
Positive
American Healthcare REIT, Inc. shows a strong revenue growth trajectory but suffers from negative net income, impacting profitability metrics. Gross profit margins have improved significantly over the years, indicating operational efficiency, yet net profit margins remain negative due to consistent net losses.
Balance Sheet
72
Positive
The company's balance sheet reflects stable equity growth and a substantial reduction in total debt, leading to a healthy debt-to-equity ratio of 0.0 in the latest fiscal year. However, the company's assets are heavily leveraged against equity, suggesting potential risk if asset values fluctuate.
Cash Flow
68
Positive
Cash flows have shown improvement with positive free cash flow growth and a strong operating cash flow to net income ratio. However, fluctuations in capital expenditures and financing activities indicate potential volatility in cash flow management.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue2.15B2.07B1.86B1.62B1.26B1.18B
Gross Profit856.55M416.77M356.83M335.97M182.01M158.58M
EBITDA292.18M315.48M324.26M233.76M159.43M165.14M
Net Income-32.80M-37.81M-71.47M-81.30M-47.79M2.16M
Balance Sheet
Total Assets4.51B4.49B4.58B4.79B4.58B3.23B
Cash, Cash Equivalents and Short-Term Investments133.49M76.70M43.45M65.05M81.60M113.21M
Total Debt1.60B1.87B2.80B2.83B2.50B1.88B
Total Liabilities2.04B2.18B3.12B3.14B2.75B2.16B
Stockholders Equity2.42B2.26B1.27B1.40B1.58B866.11M
Cash Flow
Free Cash Flow201.16M84.15M-1.26M76.25M-61.78M90.85M
Operating Cash Flow254.73M176.09M98.53M147.77M17.91M219.16M
Investing Cash Flow-38.24M-8.73M9.40M-118.58M-138.65M-147.94M
Financing Cash Flow-144.15M-134.74M-129.06M-42.92M94.11M-8.81M

American Healthcare REIT, Inc. Technical Analysis

Technical Analysis Sentiment
Positive
Last Price40.45
Price Trends
50DMA
37.29
Positive
100DMA
34.55
Positive
200DMA
31.13
Positive
Market Momentum
MACD
1.02
Negative
RSI
69.25
Neutral
STOCH
60.36
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AHR, the sentiment is Positive. The current price of 40.45 is above the 20-day moving average (MA) of 39.10, above the 50-day MA of 37.29, and above the 200-day MA of 31.13, indicating a bullish trend. The MACD of 1.02 indicates Negative momentum. The RSI at 69.25 is Neutral, neither overbought nor oversold. The STOCH value of 60.36 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AHR.

American Healthcare REIT, Inc. Risk Analysis

American Healthcare REIT, Inc. disclosed 79 risk factors in its most recent earnings report. American Healthcare REIT, Inc. reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

American Healthcare REIT, Inc. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (56)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
80
Outperform
$7.47B28.288.36%3.69%50.84%104.44%
77
Outperform
$3.54B23.8410.49%4.82%6.87%7.23%
74
Outperform
$4.43B24.286.66%6.50%6.89%240.70%
72
Outperform
$6.90B-1.51%2.47%11.62%
61
Neutral
$5.79B-7.59%7.10%-7.16%23.40%
56
Neutral
$6.59B7.48-9.67%6.29%14.87%-2.21%
51
Neutral
$2.43B-25.97%7.90%27.66%18.03%
* General Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AHR
American Healthcare REIT, Inc.
40.45
21.91
118.18%
NHI
National Health Investors
74.66
3.80
5.36%
SBRA
Sabra Healthcare REIT
18.46
3.56
23.89%
MPW
Medical Properties
4.05
-0.29
-6.68%
HR
Healthcare Realty Trust
16.47
0.20
1.23%
CTRE
CareTrust REIT
33.90
6.92
25.65%

American Healthcare REIT, Inc. Corporate Events

Private Placements and FinancingBusiness Operations and Strategy
American Healthcare REIT’s New $1 Billion Equity Offering
Neutral
Aug 8, 2025

On August 8, 2025, American Healthcare REIT, Inc. entered into a new ATM Equity Offering Sales Agreement with several financial institutions, allowing for the sale of up to $1 billion in common stock. This agreement replaces a prior offering program and aims to provide flexibility in raising capital based on market conditions and company needs, potentially impacting the company’s financial strategy and market presence.

The most recent analyst rating on (AHR) stock is a Buy with a $28.00 price target. To see the full list of analyst forecasts on American Healthcare REIT, Inc. stock, see the AHR Stock Forecast page.

Private Placements and FinancingM&A TransactionsBusiness Operations and StrategyFinancial Disclosures
American Healthcare REIT Reports Strong Q2 2025 Results
Positive
Aug 7, 2025

On August 7, 2025, American Healthcare REIT, Inc. announced its second quarter 2025 results, reporting a GAAP net income of $9.9 million and a significant growth in Same-Store Net Operating Income (NOI) of 13.9% compared to the same period in 2024. The company increased its full-year 2025 guidance due to strong performance in its senior housing and integrated senior health campuses segments. The company also completed several acquisitions and sales, including the purchase of a new senior housing operating property for $65 million and issuing shares through its equity offering program, raising substantial capital. These strategic moves are expected to enhance the company’s financial position and support its mission of providing high-quality care.

The most recent analyst rating on (AHR) stock is a Buy with a $34.00 price target. To see the full list of analyst forecasts on American Healthcare REIT, Inc. stock, see the AHR Stock Forecast page.

Shareholder MeetingsBusiness Operations and Strategy
American Healthcare REIT Holds Annual Stockholders Meeting
Neutral
Jun 26, 2025

On June 25, 2025, American Healthcare REIT, Inc. held its Annual Meeting of Stockholders where four key proposals were voted upon. The stockholders elected nine directors for a one-year term, ratified Deloitte & Touche as the independent accounting firm for 2025, approved executive compensation for 2024 on an advisory basis, and approved the 2025 Manager Equity Plan. These decisions reflect the company’s ongoing governance and strategic planning efforts, potentially impacting its operational and financial management in the coming year.

The most recent analyst rating on (AHR) stock is a Buy with a $18.00 price target. To see the full list of analyst forecasts on American Healthcare REIT, Inc. stock, see the AHR Stock Forecast page.

Dividends
American Healthcare REIT Announces Quarterly Distribution
Positive
Jun 20, 2025

On June 20, 2025, American Healthcare REIT, Inc. announced a quarterly distribution of $0.25 per share for the second quarter of 2025, payable on or about July 18, 2025, to shareholders of record as of June 30, 2025. This distribution reflects an annualized rate of $1.00 per share and underscores the company’s commitment to providing returns to its investors, potentially enhancing its attractiveness in the real estate investment sector.

The most recent analyst rating on (AHR) stock is a Buy with a $18.00 price target. To see the full list of analyst forecasts on American Healthcare REIT, Inc. stock, see the AHR Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 14, 2025